Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This is a study for patients with advanced testicular cancer. This research study involves
treatment with oxaliplatin, paclitaxel, and gemcitabine, which is an investigational
chemotherapy combination. This study is for patients who have not responded to standard
cisplatin-containing chemotherapy or the cancer has returned after such treatment.
This research is being done to assess the effectiveness of the proposed combination of
medications for this type of cancer.